High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine.

Persons

Aaron Seth Kesselheim

Venue / Journal

J Law Med Ethics

Date

Sat, 01/01/2022 - 12:00

Additional Journal Information

50(2):380-384

Authors

Tessema FA, Sarpatwari A, Rand LZ, Kesselheim AS.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/35894560